Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal midazolam added to bupivacaine for spinal anesthesia in inguinal herniorrhaphy
IRCT20151223025676N9Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in inguinal hernia comparing Bupivacaine + midazolam with Bupivacaine + normal saline control (2 arms). Primary endpoints: Time of regression of sensory block, Time of regression of motor block to modified Bromage scale 1 and 2 more. Started Nov 2018; status: completed.
02
Drugs
midazolambupivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on IRCT20151223025676N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151223025676N9.